Exact Mass: 405.14369740000006
Exact Mass Matches: 405.14369740000006
Found 183 metabolites which its exact mass value is equals to given mass value 405.14369740000006
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
4-Hydroxyphenylacetonitrile triacetylrhamnoside
4-Hydroxyphenylacetonitrile triacetylrhamnoside is a fully acetylated nitrile glycoside. It has been isolated from the leaves of Moringa oleifera (horseradish tree). It is found in fats and oils, herbs and spices, and green vegetables. 4-Hydroxyphenylacetonitrile triacetylrhamnoside is found in brassicas. Constituent of the leaves of the horseradish tree (Moringa oleifera, Moringaceae). 4-Hydroxyphenylacetonitrile triacetylrhamnoside is found in brassicas.
N-desalkyludenafil
C18H23N5O4S (405.14706780000006)
N-desalkyludenafil is a metabolite of udenafil. Udenafil is a drug used in urology to treat erectile dysfunction. It belongs to a class of drugs called PDE5 inhibitor, which many other erectile dysfunction drugs such as sildenafil, tadalafil, and vardenafil also belong to. It was developed by Dong-A Pharmaceutical Co. , Ltd. and is marketed under the trade name ZydenaTM . It is not approved for use in the United States by the U.S. Food and Drug Administration. (Wikipedia)
O-beta-D-galactopyranosyl-(1-->3)-O-beta-D-arabinofuranosyl-(1-->1)-cytosine
Ser Ala Asn Asp
Atropine sulfate monohydrate
Ala Asp Asn Ser
Ala Asp Ser Asn
Ala Asn Asp Ser
Ala Asn Ser Asp
Ala Ser Asp Asn
Ala Ser Asn Asp
Asp Ala Asn Ser
Asp Ala Ser Asn
Asp Gly Asn Thr
Asp Gly Gln Ser
Asp Gly Ser Gln
Asp Gly Thr Asn
Asp Asn Ala Ser
Asp Asn Gly Thr
Asp Asn Ser Ala
Asp Asn Thr Gly
Asp Gln Gly Ser
Asp Gln Ser Gly
Asp Ser Ala Asn
Asp Ser Gly Gln
Asp Ser Asn Ala
Asp Ser Gln Gly
Asp Thr Gly Asn
Asp Thr Asn Gly
Glu Gly Asn Ser
Glu Gly Ser Asn
Glu Asn Gly Ser
Glu Asn Ser Gly
Glu Ser Gly Asn
Glu Ser Asn Gly
Gly Asp Asn Thr
Gly Asp Gln Ser
Gly Asp Ser Gln
Gly Asp Thr Asn
Gly Glu Asn Ser
Gly Glu Ser Asn
Gly Asn Asp Thr
Gly Asn Glu Ser
Gly Asn Ser Glu
Gly Asn Thr Asp
Gly Gln Asp Ser
Gly Gln Ser Asp
Gly Ser Asp Gln
Gly Ser Glu Asn
Gly Ser Asn Glu
Gly Ser Gln Asp
Gly Thr Asp Asn
Gly Thr Asn Asp
Asn Ala Asp Ser
Asn Ala Ser Asp
Asn Asp Ala Ser
Asn Asp Gly Thr
Asn Asp Ser Ala
Asn Asp Thr Gly
Asn Glu Gly Ser
Asn Glu Ser Gly
Asn Gly Asp Thr
Asn Gly Glu Ser
Asn Gly Ser Glu
Asn Gly Thr Asp
Asn Ser Ala Asp
Asn Ser Asp Ala
Asn Ser Glu Gly
Asn Ser Gly Glu
Asn Thr Asp Gly
Asn Thr Gly Asp
Gln Asp Gly Ser
Gln Asp Ser Gly
Gln Gly Asp Ser
Gln Gly Ser Asp
Gln Ser Asp Gly
Gln Ser Gly Asp
Ser Ala Asp Asn
Ser Asp Ala Asn
Ser Asp Gly Gln
Ser Asp Asn Ala
Ser Asp Gln Gly
Ser Glu Gly Asn
Ser Glu Asn Gly
Ser Gly Asp Gln
Ser Gly Glu Asn
Ser Gly Asn Glu
Ser Gly Gln Asp
Ser Asn Ala Asp
Ser Asn Asp Ala
Ser Asn Glu Gly
Ser Asn Gly Glu
Ser Gln Asp Gly
Ser Gln Gly Asp
Thr Asp Gly Asn
Thr Asp Asn Gly
Thr Gly Asp Asn
Thr Gly Asn Asp
Thr Asn Asp Gly
Thr Asn Gly Asp
4-Hydroxyphenylacetonitrile triacetylrhamnoside
Heroin hydrochloride
C21H24ClNO5 (405.13429240000005)
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics
fmoc-(s)-3-amino-3-(2-fluoro-phenyl)-propionic acid
C24H20FNO4 (405.13762920000005)
fmoc-(r)-3-amino-3-(3-fluoro-phenyl)-propionic acid
C24H20FNO4 (405.13762920000005)
1-(2,2-Dimethoxyethyl)-1,4-dihydro-4-oxo-3-(phenylmethoxy)-2,5-pyridinedicarboxylic acid 2,5-dimethyl ester
fmoc-(r)-3-amino-3-(2-fluoro-phenyl)-propionic acid
C24H20FNO4 (405.13762920000005)
2-[[(4-Chlorophenyl) methylhydrazono]methyl]-1-(2-methoxyethyl)-3,3-dimethyl-3H-indolium chloride
morclofone
C21H24ClNO5 (405.13429240000005)
R - Respiratory system > R05 - Cough and cold preparations > R05D - Cough suppressants, excl. combinations with expectorants C78273 - Agent Affecting Respiratory System > C66917 - Antitussive Agent
p-Amidinophenyl p-(6-amidino-2-indolyl)phenyl ether dihydrochloride
C22H20ClN5O (405.13563000000005)
fmoc-(r)-3-amino-3-(4-fluoro-phenyl)-propionic acid
C24H20FNO4 (405.13762920000005)
Spiro[9H-fluorene-9,8-[8H]indolo[3,2,1-de]acridine]
Spiro[9H-fluorene-9,7(12H)-indeno[1,2-a]carbazole]
3-n-fmoc-3-(4-fluorophenyl)propionic acid
C24H20FNO4 (405.13762920000005)
fmoc-(s)-3-amino-3-(3-fluoro-phenyl)-propionic acid
C24H20FNO4 (405.13762920000005)
(S)-3-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)-3-(4-FLUOROPHENYL)PROPANOIC ACID
C24H20FNO4 (405.13762920000005)
Mazaticol
N - Nervous system > N04 - Anti-parkinson drugs > N04A - Anticholinergic agents > N04AA - Tertiary amines C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent
4-[(5-{[4-(3-Chlorophenyl)-3-oxopiperazin-1-YL]methyl}-1H-imidazol-1-YL)methyl]benzonitrile
C22H20ClN5O (405.13563000000005)
N-Des[2-(1-methyl-2-pyrrolidinyl)ethyl] Udenafil
C18H23N5O4S (405.14706780000006)
2-[(5-Phenyl-1,3,4-oxadiazol-2-yl)thio]-1-(2,2,4,6-tetramethyl-1-quinolinyl)ethanone
2-{3-[(2s)-4,4-Difluoro-2-(Pyrrolidin-1-Ylcarbonyl)pyrrolidin-1-Yl]-3-Oxopropyl}-Isoindole-1,3(2h)-Dione
7,8-dimethyl-4-oxo-10-[(2S,3R,4S,5R)-2,3,4,5,6-pentahydroxyhexyl]benzo[g]pteridin-2-olate
1-(2-Chloro-4-methylphenyl)-3-[[1-[(3-chlorophenyl)methyl]-4-piperidinyl]methyl]urea
1-(4-Chlorophenyl)-5-[1-[(2-methylpropan-2-yl)oxy-oxomethyl]-4-piperidinyl]-4-pyrazolecarboxylic acid
C20H24ClN3O4 (405.14552540000005)
1-[1-[4-[(4-chlorophenyl)methoxy]phenyl]-2,5-dimethylpyrrol-3-yl]-N-(1,2,4-triazol-4-yl)methanimine
C22H20ClN5O (405.13563000000005)
Diethyl 3-methyl-5-[[2-(pyridin-2-ylmethylamino)acetyl]amino]thiophene-2,4-dicarboxylate
C19H23N3O5S (405.13583480000005)
N-[2-(4-methoxyphenyl)ethyl]-2-nitro-4-(1-pyrrolidinylsulfonyl)aniline
C19H23N3O5S (405.13583480000005)
5-(4-ethylsulfonyl-1-piperazinyl)-2-nitro-N-(3-pyridinylmethyl)aniline
C18H23N5O4S (405.14706780000006)
5-amino-N-(2-methoxy-5-methylphenyl)-1-[[3-(trifluoromethyl)phenyl]methyl]-4-triazolecarboxamide
2-(Butylamino)benzoic acid [2-oxo-2-(4-sulfamoylanilino)ethyl] ester
C19H23N3O5S (405.13583480000005)
(1S,5R)-6-(2-methylphenyl)sulfonyl-7-[4-(3-pyridinyl)phenyl]-3,6-diazabicyclo[3.1.1]heptane
[(2S,3R)-2-(hydroxymethyl)-3-phenyl-6-(2-thiazolylmethyl)-1,6-diazaspiro[3.3]heptan-1-yl]-phenylmethanone
[(2S,3S)-2-(hydroxymethyl)-3-phenyl-6-(2-thiazolylmethyl)-1,6-diazaspiro[3.3]heptan-1-yl]-phenylmethanone
[(2R,3R)-2-(hydroxymethyl)-3-phenyl-6-(2-thiazolylmethyl)-1,6-diazaspiro[3.3]heptan-1-yl]-phenylmethanone
[4,5-Diacetyloxy-6-[4-(cyanomethyl)phenoxy]-2-methyloxan-3-yl] acetate
Adenosine, N-(2-hydroxycyclopentyl)-, (1S-trans)-[CAS]
Glu-Glu-Glu
A tripeptide composed of three L-glutamic acid units joined by peptide linkages.
JZP-361
C22H20ClN5O (405.13563000000005)
JZP-361 is a potent, reversible and selective inhibitor of human recombinant MAGL (hMAGL) with an IC50 of 46 nM. JZP-361 also shows antihistaminergic activities and can be used for asthma research[1]. JZP-361 is a potent, reversible and selective inhibitor of human recombinant MAGL (hMAGL) with an IC50 of 46 nM. JZP-361 also shows antihistaminergic activities and can be used for asthma research[1].
(2s,3r,4r,5s,6s)-4,5-bis(acetyloxy)-2-[4-(cyanomethyl)phenoxy]-6-methyloxan-3-yl acetate
(2s,3r,4s,5r,6r)-2-{[(2r,3s,4s,5r)-4-hydroxy-5-(2-hydroxy-4-iminopyrimidin-1-yl)-2-(hydroxymethyl)oxolan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2r)-2-methyl-n-{2-[11-(methylsulfanyl)-12-oxo-8,14-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,10,13,15-octaen-10-yl]ethyl}butanimidic acid
2-{[4-hydroxy-5-(2-hydroxy-4-iminopyrimidin-1-yl)-2-(hydroxymethyl)oxolan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
4,5-bis(acetyloxy)-2-[4-(cyanomethyl)phenoxy]-6-methyloxan-3-yl acetate
5-({1,4-bis[(4-hydroxyphenyl)methyl]imidazol-2-yl}imino)-2-hydroxy-3-methylimidazol-4-one
C21H19N5O4 (405.14369740000006)
(2s)-2-{[(2s)-2-{[(2s)-2-amino-4-carboxy-1-hydroxybutylidene]amino}-4-carboxy-1-hydroxybutylidene]amino}pentanedioic acid
5-({1-[(4-hydroxyphenyl)methyl]-4-[(4-methoxyphenyl)methyl]imidazol-2-yl}amino)-3h-imidazole-2,4-dione
C21H19N5O4 (405.14369740000006)